副甲状腺ホルモンの世界市場レポート 2024

副甲状腺ホルモンの市場規模は、今後数年間で着実に成長すると予想されます。 9.6%の年間複合成長率（CAGR）で、2028年には35億米ドルに成長すると予想されます。予測期間中に予想される成長は、高齢者人口の拡大、民間ヘルスケア部門の成長、新たな適応症の出現、精密医療の進歩、骨の健康に対する意識の高まり、アクセシビリティの向上など、いくつかの重要な要因に関連している可能性があります。ヘルスケアサービスに。この期間中に予想される主な動向には、副甲状腺ホルモン検査の進歩、ドラッグデリバリー方法の革新、併用療法の開発、デジタルヘルステクノロジーの統合、業界内の持続可能性とグリーンイニシアチブへの焦点が含まれます。

副甲状腺ホルモンの市場は、骨粗鬆症の有病率の上昇により成長が見込まれています。 2021年1月現在、骨折リスクの増加につながる骨量の減少を特徴とする骨粗鬆症が、主に閉経後の女性と高齢者である約140万人のカナダ人に影響を及ぼしています。カルシウムレベルを調節する副甲状腺ホルモンは、骨粗鬆症患者の骨折リスクを軽減するために毎日皮下注射によって投与されます。この骨粗鬆症症例の急増は、副甲状腺ホルモン市場の拡大に寄与すると予想されます。

低カルシウム血症の発生率の増加により、副甲状腺ホルモン市場が拡大すると予測されています。血中カルシウム濃度の低下を特徴とする低カルシウム血症は、カルシウム調節において極めて重要な副甲状腺ホルモンによって管理されます。 2021年4月の報告書では、35億人以上の人がカルシウム欠乏症のリスクにさらされており、治療に対する市場の需要が高まっていると報告されています。 副甲状腺ホルモンは低カルシウム血症の管理に役立つため、市場の成長はこの発生率の増加によって裏付けられています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の副甲状腺ホルモン市場、疾患タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 低カルシウム血症
• 副甲状腺機能低下症
• 世界の副甲状腺ホルモン市場、製品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 組換え副甲状腺ホルモン
• 副甲状腺ホルモン類似体
• 世界の副甲状腺ホルモン市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の副甲状腺ホルモン市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の副甲状腺ホルモン市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副甲状腺ホルモン市場の競合情勢
• 副甲状腺ホルモン市場の企業プロファイル
  • Pfizer Inc.
  • Eli Lilly and Company
  • Radius Health Inc.
  • Shire plc
  • Ascendis Pharma

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Parathyroid hormone, produced by the parathyroid gland, plays a crucial role in the body's calcium storage and utilization. Elevated levels of this hormone can lead to high blood calcium levels, potentially indicating a medical condition. It's also referred to as PTH, parathyrin, or parathormone.

Within the realm of parathyroid hormone products, there are recombinant parathyroid hormone and parathyroid hormone analogs. Recombinant parathyroid hormone, resembling natural parathyroid hormone, is utilized in treating osteoporosis. These products cater to conditions like hypocalcemia and hypoparathyroidism and are used across various healthcare settings such as hospitals, clinics, and others.

The parathyroid hormone market research report is one of a series of new reports from The Business Research Company that provides parathyroid hormone market statistics, including parathyroid hormone industry global market size, regional shares, competitors with a parathyroid hormone market share, detailed parathyroid hormone market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid hormone industry. This parathyroid hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parathyroid hormone market size has grown steadily in recent years. It will grow from $2.35 billion in 2023 to $2.43 billion in 2024 at a compound annual growth rate (CAGR) of 3.5%. The growth observed in the historical period can be attributed to several factors, including an increased prevalence of chronic kidney disease, a growing awareness of disorders related to parathyroid hormone, a rising demand for parathyroid hormone analogs, increased governmental funding allocated for parathyroid hormone research, and an overall rise in disposable incomes.

The parathyroid hormone market size is expected to see steadily grown in the next few years. It will grow to $3.5 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. Anticipated growth in the forecast period can be linked to several key factors, including the expanding geriatric population, the growth of private healthcare sectors, the emergence of new indications, the advancement of precision medicine, a heightened awareness of bone health, and an increased accessibility to healthcare services. Major trends expected during this period encompass advancements in parathyroid hormone testing, innovations in drug delivery methods, the development of combination therapies, integration of digital health technologies, and a focus on sustainability and green initiatives within the industry.

The market for parathyroid hormones anticipates growth due to rising osteoporosis prevalence. In January 2021, Osteoporosis, characterized by reduced bone mass leading to higher fracture risks, affects approximately 1.4 million Canadians, primarily postmenopausal women and the elderly. Parathyroid hormones, regulating calcium levels, are administered via daily subcutaneous injections to mitigate fracture risks in osteoporosis patients. This surge in osteoporosis cases is expected to contribute to the expansion of the parathyroid hormone market.

The escalating incidence of hypocalcemia is projected to drive the parathyroid hormone market. Hypocalcemia, a condition marked by low blood calcium levels, is managed by parathyroid hormones, pivotal in calcium regulation. In April 2021, Reports indicate over 3.5 billion individuals at risk of calcium deficiency, spurring a market demand for treatments. As parathyroid hormones aid in managing hypocalcemia, their market growth is substantiated by this increasing incidence.

Companies within the parathyroid hormone market prioritize biosimilar development. Biosimilars, akin to FDA-approved biologics, offer cost-effective treatment without compromising efficacy. Notably, Theramex introduced Livogiva in January 2021, a novel form of teriparatide for postmenopausal women at high osteoporosis risk. This emphasis on biosimilars signifies a strategic focus of parathyroid hormone manufacturers to broaden treatment accessibility while maintaining standards.

Key players in the parathyroid hormone market concentrate on innovative products like upasita IV Injection syringes to drive revenues. Specifically designed for intravenous delivery, these syringes serve to administer medications directly into the bloodstream. Sanwa Kagaku Kenkyusho Co. Ltd.'s upasita IV Injection syringes, launched in August 2021, target secondary hyperparathyroidism in dialysis patients by regulating excessive parathyroid hormone secretion. This innovation caters to enhanced treatment options within the market segment.

Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, announced its decision to acquire Shire Plc for $46 billion. The acquisition is expected to accelerate the delivery of medicines to patients around the world with an expanded scale and geographical footprint by Takeda Pharmaceutical Company. It also increases the levels of the parathyroid hormone, natpara. Shire Plc is a pharmaceutical company based in the United States that specializes in innovative and rare disease drugs.

Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Shire PLC, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, Becton Dickinson and Company, Ethicon Inc., Genentech Inc., Medtronic Inc., Mylan Laboratories, Novo Nordisk, Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings Inc.

North America was the largest region in the parathyroid hormone market in 2023. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The parathyroid hormone market consists of sales of parathormone and calcitonin. Values in this market are ''factory gate values,'' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parathyroid Hormone Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on parathyroid hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parathyroid hormone? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The parathyroid hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Disease Type: Hypocalcemia; Hypoparathyroidism
• 2) By Product Type: Recombinant Parathyroid Hormone; Parathyroid Hormone Analogues
• 3) By End-User: Hospitals; Clinics; Other End-Users
• Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Radius Health Inc.; Shire plc; Ascendis Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Parathyroid Hormone Market Characteristics

3. Parathyroid Hormone Market Trends And Strategies

4. Parathyroid Hormone Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Parathyroid Hormone Market Size and Growth

• 5.1. Global Parathyroid Hormone Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Parathyroid Hormone Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Parathyroid Hormone Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Parathyroid Hormone Market Segmentation

• 6.1. Global Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hypocalcemia
• Hypoparathyroidism
• 6.2. Global Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Recombinant Parathyroid Hormone
• Parathyroid Hormone Analogues
• 6.3. Global Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Other End-Users

7. Parathyroid Hormone Market Regional And Country Analysis

• 7.1. Global Parathyroid Hormone Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Parathyroid Hormone Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Parathyroid Hormone Market

• 8.1. Asia-Pacific Parathyroid Hormone Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Parathyroid Hormone Market

• 9.1. China Parathyroid Hormone Market Overview
• 9.2. China Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Parathyroid Hormone Market

• 10.1. India Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Parathyroid Hormone Market

• 11.1. Japan Parathyroid Hormone Market Overview
• 11.2. Japan Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Parathyroid Hormone Market

• 12.1. Australia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Parathyroid Hormone Market

• 13.1. Indonesia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Parathyroid Hormone Market

• 14.1. South Korea Parathyroid Hormone Market Overview
• 14.2. South Korea Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Parathyroid Hormone Market

• 15.1. Western Europe Parathyroid Hormone Market Overview
• 15.2. Western Europe Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Parathyroid Hormone Market

• 16.1. UK Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Parathyroid Hormone Market

• 17.1. Germany Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Parathyroid Hormone Market

• 18.1. France Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Parathyroid Hormone Market

• 19.1. Italy Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Parathyroid Hormone Market

• 20.1. Spain Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Parathyroid Hormone Market

• 21.1. Eastern Europe Parathyroid Hormone Market Overview
• 21.2. Eastern Europe Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Parathyroid Hormone Market

• 22.1. Russia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Parathyroid Hormone Market

• 23.1. North America Parathyroid Hormone Market Overview
• 23.2. North America Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Parathyroid Hormone Market

• 24.1. USA Parathyroid Hormone Market Overview
• 24.2. USA Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Parathyroid Hormone Market

• 25.1. Canada Parathyroid Hormone Market Overview
• 25.2. Canada Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Parathyroid Hormone Market

• 26.1. South America Parathyroid Hormone Market Overview
• 26.2. South America Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Parathyroid Hormone Market

• 27.1. Brazil Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Parathyroid Hormone Market

• 28.1. Middle East Parathyroid Hormone Market Overview
• 28.2. Middle East Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Parathyroid Hormone Market

• 29.1. Africa Parathyroid Hormone Market Overview
• 29.2. Africa Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Parathyroid Hormone Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Parathyroid Hormone Market Competitive Landscape And Company Profiles

• 30.1. Parathyroid Hormone Market Competitive Landscape
• 30.2. Parathyroid Hormone Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Eli Lilly and Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Radius Health Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Shire plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Ascendis Pharma
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Parathyroid Hormone Market Competitive Benchmarking

32. Global Parathyroid Hormone Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Parathyroid Hormone Market

34. Parathyroid Hormone Market Future Outlook and Potential Analysis

• 34.1 Parathyroid Hormone Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Parathyroid Hormone Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Parathyroid Hormone Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer